TOBAM’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-44,861
| Closed | -$767K | – | 274 |
|
|
2025
Q2 | $767K | Buy |
44,861
+7,053
| +19% | +$301K | 0.3% | 71 |
|
|
2025
Q1 | $2.41M | Buy |
37,808
+8,886
| +31% | +$935K | 1.03% | 35 |
|
|
2024
Q4 | $3.52M | Sell |
28,922
-19,968
| -41% | -$2.45M | 1.07% | 35 |
|
|
2024
Q3 | $6.11M | Sell |
48,890
-293
| -0.6% | -$40.5K | 1.11% | 35 |
|
|
2024
Q2 | $7.77M | Sell |
49,183
-70,725
| -59% | -$9.09M | 1.22% | 29 |
|
|
2024
Q1 | $15.5M | Sell |
119,908
-36,138
| -23% | -$4.43M | 1.39% | 26 |
|
|
2023
Q4 | $15M | Buy |
156,046
+7,105
| +5% | +$682K | 1.32% | 31 |
|
|
2023
Q3 | $18.1M | Buy |
148,941
+42,181
| +40% | +$4.77M | 1.45% | 29 |
|
|
2023
Q2 | $12.2M | Buy |
106,760
+94,060
| +741% | +$12.1M | 0.92% | 39 |
|
|
2023
Q1 | $1.75M | Buy |
12,700
+4,681
| +58% | +$607K | 0.12% | 96 |
|
|
2022
Q4 | $1.04M | Buy |
8,019
+4,214
| +111% | +$488K | 0.07% | 107 |
|
|
2022
Q3 | $421K | Buy |
+3,805
| New | +$384K | 0.03% | 158 |
|
|
2021
Q2 | – | Sell |
-371,107
| Closed | -$27.7M | – | 442 |
|
|
2021
Q1 | $27.7M | Buy |
371,107
+294,304
| +383% | +$27.2M | 1.18% | 34 |
|
|
2020
Q4 | $13.1M | Sell |
76,803
-29,083
| -27% | -$4.31M | 0.58% | 58 |
|
|
2020
Q3 | $14.9M | Sell |
105,886
-31,130
| -23% | -$4.73M | 0.74% | 46 |
|
|
2020
Q2 | $22M | Buy |
137,016
+59,315
| +76% | +$8.07M | 1.41% | 30 |
|
|
2020
Q1 | $7.6M | Buy |
77,701
+56,012
| +258% | +$6.4M | 0.6% | 52 |
|
|
2019
Q4 | $2.8M | Buy |
21,689
+21,193
| +4,273% | +$2.14M | 0.17% | 77 |
|
|
2019
Q3 | $37K | Buy |
+496
| New | +$58.6K | ﹤0.01% | 118 |
|
|
2019
Q2 | – | Sell |
-246
| Closed | -$29K | – | 140 |
|
|
2019
Q1 | $29K | Sell |
246
-95
| -28% | -$12.2K | ﹤0.01% | 137 |
|
|
2018
Q4 | $37K | Buy |
+341
| New | +$42.6K | ﹤0.01% | 150 |
|
Other funds holding SRPT
EAM
